Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 1c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q4 EPS of ($0.77), $0.01 better than the analyst estimate of ($0.78).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Fiverr International (FVRR) Misses Q2 EPS by 2c; updates guidance
• VAT Group AG (VACN:SW) PT Raised to CHF650 at RBC Capital
• Basic-Fit NV (BFIT:NA) PT Raised to EUR47.50 at UBS